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One of the least
attractive aspects of
being an editor is
dealing with the
possibility of scien-
tific misconduct or
fraud.One of the least attractive aspects of being an editor is dealing with the possibil-ity of scientific misconduct or fraud. Aside from the fundamental unpleasant-ness of the matter, editors are poorly equipped to evaluate possible misconduct
since we neither have access to the raw data of submissions nor the time and manpower
to acquire and analyze it if we did. Moreover, individuals who are much better posi-
tioned to identify research misbehavior are typically disinclined to do so. Similar to jour-
nals, the parent institution has no desire to have its reputation sullied, nor do collabora-
tors, who have the added incentive of preserving the academic equity of publications in
which they have been involved. Further, much scientific misconduct is not deliberate,
but rather the result of unintentional error or ignorance of accepted standards for issues,
such as duplicate publication or self plagiarism. Although each instance of scientific
transgression that is exposed casts a shadow of suspicion on the validity of the entire
research enterprise, it is essential to reveal erroneous data or wrongdoing not only for
basic integrity, but also so that it is not perpetuated in other publications or teachings.
It may be that there is something so sinister about misconduct that it attracts undue
publicity and therefore an exaggeration of its prevalence. Indeed, in the current era of
the Internet and multiple social media outlets, news of academic fraud attracts headlines
and spreads rapidly. However, a brief perusal of PubMed citations under scientific mis-
conduct reveals impressive evidence of the frequency and significance of this problem. A
recent survey of British investigators revealed that 13% reported knowledge of colleagues
“inappropriately adjusting, excluding, altering, or fabricating data” (1), and a meta-analy-
sis of survey data found that 14% of respondents were aware of behaviors by others that
distorted scientific knowledge, while 2% admitted such actions by themselves (2).
Clearly, given the emphasis upon evidence-based medicine, this is a serious issue.
A variety of actions can fall under the category of scientific misconduct (3). The in-
vestigation itself may be totally unethical, such as the study evaluating the natural history
of syphilis after the discovery of penicillin. Hopefully, such experiments have been abol-
ished by the creation of institution review boards (IRBs), although IRB approval can be
omitted or IRB rules circumvented by unethical investigators. More commonly today,
scientific wrongdoing fall under one of several general groupings: fabrication or falsifica-
tion, plagiarism, failure to obtain informed consent, violation of IRB restrictions, lack of
disclosure of conflict of interest, duplicate publication, and perhaps failure to report mis-
conduct on the part of others. Obviously, the gravity of misconduct varies, ranging from
data fabrication and absence of informed consent to duplicate publication and self pla-
giarism. Of greatest concern are transgressions that endanger patients or result in erro-
neous scientific information.
Just as the seriousness of scientific misconduct can vary, so can the certainty with
which it is known to exist. As stated above, the evidence of wrongdoing is often difficult
to uncover, and guilt is frequently hard to assign with confidence. It follows that the
actions taken by editors and journals are also often variable. In fact, a spectrum of mea-
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post an errata indicating that corrections to the published
manuscript are required. Typically errata relate to aspects
of the paper that do not change the findings in a signifi-
cant way. If issues of a more serious nature exist, an ‘Ex-
pression of Concern’ can be published conveying that the
validity of an article is in question. Given the potential
consequences of such an expression, I believe that this
should usually be reserved for papers for which additional
investigation is under way to resolve the issue. However,
on occasion the evidence to resolve the question may not
be available, such as when records are destroyed, which in
itself may be considered misconduct. When portions of a
manuscript are clearly in error, a partial retraction can be
made. The obvious inference in such cases is that the re-
mainder of the data and analysis are valid, although inac-
curacies in one portion of a paper always raise suspicion
about other data.
The action of the greatest gravity is a retraction or a
formal withdrawal of a manuscript. Retraction may be
caused by the post-publication discovery of errors by the
authors, or by the publication of new findings, or the in-
ability to reproduce the original results by other investiga-
tors. The retraction may be voluntary, or without permis-
sion of at least some of the authors. In such cases the
editor, home institution, or at least one of the authors has
determined that the paper’s findings are inaccurate, de-
spite the fact that not all authors are in agreement with
this conclusion. The rules of the National Library of
Medicine (NLM) stipulate that a manuscript may be re-
tracted by the editor, the sponsoring institution, or any
one of the authors. The NLM does not distinguish man-
uscripts that are withdrawn due to honest mistakes from
those that involve misconduct, a policy that I find regret-
table. Interestingly, withdrawn manuscripts continue to be
listed in MEDLINE, albeit with a notice of retraction,
and evidence exists that they continue to be cited by other
articles (5).
Given the gravity and consequences of manuscript re-
traction, it is obvious that this should not be undertaken
lightly. A definition in that great medical resource, Wiki-
pedia, states that a retraction of a published scientific arti-
cle indicates that the data and conclusions of the original
article should not be used as part of the foundation for
future research, implying that the data is erroneous. Obvi-
ously this creates some interesting dilemmas. The miscon-
duct of a given manuscript may involve not obtaining in-
formed consent or not revealing clear conflicts of interest,while the fundamental data and conclusions are accurate.
In such a case, retraction would not seem to be the best
option. Similarly, the inability to produce all raw data due
to loss or destruction of at least partial recordings is not
clear evidence that the basic findings are inaccurate. Deci-
sions in such cases are difficult, and are correct only in
retrospect. Nevertheless, these are the circumstances in
which editors, including those of this journal, can find
themselves. As is our universal policy, in such cases the
JACC editors convene as a group and reach a consensus
decision.
Thankfully, we at JACC have not often found ourselves
confronted with the issue of scientific misconduct. Our
retractions have usually been initiated by the authors of
the original article upon finding an honest error. In those
cases where suspicions of misconduct have arisen, we have
always asked the authors of the articles in question to re-
spond, and usually give them the benefit of any doubt.
However, if we can believe that over 10% of investigators
are aware of scientific misconduct, either we as editors
have been extraordinarily discerning of such transgressions
during the review process, or we have occasionally been
duped. This perhaps would not be surprising given the
limited arsenal available to us to identify misconduct. In
the final analysis, however, the validity of the medical
literature has to be based upon the integrity of the com-
munity of investigators. Based upon my 35 years in aca-
demic medicine and research, I think that this confidence
is reasonably well placed. I do not anticipate many retrac-
tions in JACC in the future.
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